|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| RP Management LLC
✚
|
|
|---|---|
| CRD # | 161569 |
| SEC # | 801-74235 |
| CIK # | 0001507673 |
| AUM | $1.4 B (2025-06-15) |
| Employees | 2 (50% Investors, 0% Brokers) |
| Phone | 212-883-0200 |
| Address | 110 East 59th Street, Suite 3300 New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Royalty Pharma Select | [2021-04-29] | 164.5 | 40.9 |
| HF | RPI Intermediate Finance Partnership LP | [2021-04-29] | 10.5 | 1,357.3 |
| PE | RPI International Holdings 2019 LP | [2020-03-27] | 0.0 | 1,046.3 |
| PE | RPS Biopharma Holdings LP | [2020-03-27] | 149.6 | 32.8 |
| PE | RPS Biopharma Holdings LP | 2018-03-29 | 72.8 | |
| PE | RPS Biopharma Investments LP | [2018-03-29] | 164.5 | 29.6 |
| PE | Royalty Pharma Cayman Holdings 2008 LP | [2012-02-15] | 0.7 | |
| PE | Royalty Pharma Cayman Holdings LP | 2012-02-15 | 61.9 | |
| PE | Royalty Pharma Cayman Partners 2008 LP | 2012-02-15 | 0.7 | |
| PE | Royalty Pharma Cayman Partners LP | [2012-02-15] | 61.9 | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 1.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 1.4 |
| By Discretionary | ||
| Discretionary | 7 | 1.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 1.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 1.4 | |
| Total | 7 | 1.4 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Rory Riggs | 35 | ||
| Pablo Legorreta | 12 | ||
| Pharma Management Cayman Ltd | 3 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001507673] | |
| 3 | [0001507673] | |
| 4 | [0001507673] |
| Form 3/4/5 Subject | 2011 - 2025 |
|---|---|
| Epizyme, Inc. | |
| Legorreta Pablo G. | |
| RPI Finance Trust | |
| RP Management, LLC | |
| Royalty Pharma Investments 2019 ICAV |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Content Partners LLC
✚
|
CA | 1.4 |
|
ParaFi Capital LP
✚
|
NY | 1.4 |
|
Alta Park Capital LP
✚
|
CA | 1.4 |
|
Pickering Energy Partners LP
✚
|
TX | 1.4 |
|
Long Path Partners LP
✚
|
CT | 1.3 |
|
Woodson Capital Management LP
✚
|
CT | 1.3 |
|
Pleiad Investment Advisors Limited
✚
|
1.3 | |
|
Ospraie Management LLC
✚
|
NY | 1.3 |
|
Wexford Capital LP
✚
|
FL | 1.3 |
|
Bedford Ridge Capital LP
✚
|
NY | 1.3 |